Data / Form D filings / TesoRx Pharma, LLC
TesoRx Pharma, LLC: Form D filings
TesoRx Pharma, LLC, a pharmaceuticals company in Menlo Park, CA, filed 5 Form D notices with the SEC between 2012 and 2019. The latest, on May 3, 2019, reports $289,000 sold of a $5.2 million offering to 2 investors.
Find out what TesoRx Pharma, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 325 SHARON PARK DRIVE, SUITE 739, Menlo Park, CA, 94025
- Phone
- (650) 490-4820
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1554258
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 3, 2019 | New notice | $5,200,000 | $289,000 | $4,911,000 | 2 | Apr 19, 2019 | sec.gov |
| Jul 13, 2016 | New notice | $5,000,000 | $697,532 | $4,302,468 | 8 | Jul 12, 2016 | sec.gov |
| May 15, 2014 | New notice | $10,068,256 | $1,985,000 | $8,083,256 | 3 | May 8, 2014 | sec.gov |
| Jul 30, 2013 | New notice | $5,000,000 | $3,922,979 | $1,077,021 | 9 | Jul 22, 2013 | sec.gov |
| Jul 16, 2012 | New notice | $6,597,654 | $5,922,610 | $675,044 | 19 | Jun 26, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Willem A Robberts | Executive Officer, Director | |
| Ramachandran Thirucote | Executive Officer, Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Apr 29, 2019 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TesoRx Pharma, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.